References
- Kilis-Pstrusinska K, Szajerka U, Zwolinska D. Unspecific increase of tumor markers in a girl with nephrotic syndrome and ovarian teratoma. Renal Fail. 2013;35:654–656.
- Atkinson BF, Ernst CS, Herlyn M, Steplewski Z, Sears HF, Koprowski H. Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res. 1982;42:4820–4823.
- Malaguarnera G, Giordano M, Paladina I, et al. Markers of bile duct tumors. World J Gastrointest Oncol. 2011;3:49–59.
- Ohshio G, Manabe T, Watanabe Y, et al. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: Evaluation of the influence of obstructive jaundice. Am J Gastroenterol. 1990;85:1370–1376.
- Uygur-Bayramicli O, Dabak R, Orbay E, et al. Type 2 diabetes mellitus and CA 19-9 levels. World J Gastroenterol. 2007;13:5357–5359.
- Kodama T, Satoh H, Ishikawa H, Ohtsuka M. Serum Levels of CA19-9 in patients with nonmalignant respiratory diseases. J Clin Lab Anal. 2007;21:103–106.
- Aybek H, Aybek Z, Sinik Z, Demir S, Sancak B, Tuncay L. Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis. Int J Urol. 2006;13:1380–1384.
- Lopes RI, Denes FT, Bartolamei MG, et al. Serum and urinary values of CA 19-9 and TGFss1 in a rat model of partial or complete ureteral obstruction. Eur J Pediatr Surg. 2015;25:513–519.
- Suzuki K. Elevation of serum and urinary carbohydrate antigen 19–9 in benign hydronephrosis. Int J Urol. 2007;14:668–669.
- Suzuki K, Muraishi O, Tokue A. The correlation of serum carbohydrate antigen 19–9 with benign hydronephrosis. J Urol. 2002;167:16–20.
- Kajbafzadeh A-M, Elmi A, Talab SS, Emami H, Esfahani SA, Saeedi P. Urinary and serum carbohydrate antigen 19–9 as a biomarker in ureteropelvic junction obstruction in children. J Urol. 2010;183:2353–2360.
- Moak JH, Lyons MS, Lindsell CJ. Bedside renal ultrasound in the evaluation of suspected ureterolithiasis. Am J Emerg Med. 2012;30:218–221.
- Daggulli M, Utangac MM, Dede O, et al. Potential biomarkers for the early detection of acute kidney injury after percutaneous nephrolithotripsy. Renal Fail. 2016;38:151–156.
- Inamoto T, Itoh S, Azuma H, Katsuoka Y, Takasaki N. Giant hydronephrosis with increased carbohydrate antigen 19–9 both in serum and fluid. Hinyokika Kiyo. 2004;50:485–488.
- Meyer A, Kausch I, Krüger S, Fetscher S, Böhle A, Jocham D. Elevation of CA 19–9 in giant hydronephrosis induced by a renal calculus. Urology. 2004;63:381–382.
- Kutlu O, Celik O, Koksal IT, Yigit S, Danisman A. Serum carbohydrate antigen 19-9 levels in patients with unilateral hydronephrosis due to urinary lithiasis. Minerva Urol Nefrol. 2012;64:217–221.
- Atar A, Oktar T, Kucukgergin C, et al. The roles of serum and urinary carbohydrate antigen 19–9 in the management of patients with antenatal hydronephrosis. J Pediatr Urol. 2015;11:133.e1–133.e5.
- Ito S, Gejyo F. Elevation of serum CA19-9 levels in benign diseases. Intern Med. 1999;38:840–841.